Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1056/nejmp2216703

Type

Journal article

Journal

The New England journal of medicine

Publication Date

02/2023

Volume

388

Addresses

From the Harvard T.H. Chan School of Public Health, Boston (F.C.); the Research Institute of Health Sciences, Ouagadougou, Burkina Faso (A.D.); Medicines for Malaria Venture, Geneva (C.D.); Shoklo Malaria Research Unit, Mae Sot (F.N., A.P.P.), and the Mahidol Oxford Tropical Medicine Research Unit (N.W.), Bangkok - both in Thailand; Monash University, Clayton, Australia (S.O.); and Imperial College London, London (F.O.).

Keywords

Humans, Malaria, Biomedical Research